Francesco Baratta1,2, Daniele Pastori1,2, Licia Polimeni1, Tommaso Bucci3, Fabrizio Ceci4, Cinzia Calabrese1, Ilaria Ernesti5, Gaetano Pannitteri6, Francesco Violi1, Francesco Angelico7, Maria Del Ben1. 1. I Clinica Medica, Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy. 2. Department of Anatomical, Histological, Forensic Medicine and Orthopedics Sciences-Sapienza University of Rome, Rome, Italy. 3. Department of Medical Specialties, Salerno University of Medicine, Salerno, Italy. 4. Department of Cellular Biotechnologies and Hematology, "La Sapienza" University, Policlinico Umberto I Hospital, Rome, Italy. 5. Department of Experimental Medicine, Section of Medical Pathophysiology, Endocrinology and Nutrition, Sapienza University, Rome, Italy. 6. Department of Cardiovascular, Respiratory, Nephrologic, Anaesthesiologic and Geriatric Sciences, Sapienza University of Rome, Rome, Italy. 7. Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
Abstract
OBJECTIVES: The prevalence of cardiometabolic disorders, including non-alcoholic fatty liver disease (NAFLD), is increasing in western countries, because of changes in lifestyle and dietary habits. Mediterranean Diet (Med-Diet) is effective for cardiovascular prevention, but its relationship with NAFLD has been scarcely investigated. METHODS: We included 584 consecutive outpatients presenting with one or more cardiovascular risk factor such as type 2 diabetes mellitus (T2DM), arterial hypertension, overweight/obesity, and dyslipidemia. Liver steatosis was assessed using ultrasonography. Med-Diet adherence was investigated by a validated semiquantitative nine-item dietary questionnaire; patients were divided into low, intermediate, and high adherence. Insulin resistance was defined by the 75th percentile of homeostasis model of insulin resistance (HOMA-IR; ≥3.8). RESULTS: The mean age was 56.2±12.4 years and 38.2% were women. Liver steatosis was present in 82.7%, and its prevalence decreased from low to high adherence group (96.5% vs. 71.4%, P<0.001). In a multiple logistic regression analysis, hypertriglyceridemia (odds ratio (OR): 2.913; P=0.002), log (ALT) (OR: 6.186; P<0.001), Med-Diet adherence (intermediate vs. low OR: 0.115; P=0.041, high vs. low OR: 0.093; P=0.030), T2DM (OR: 3.940; P=0.003), and high waist circumference (OR: 3.012; P<0.001) were associated with NAFLD. Among single foods, low meat intake (OR: 0.178; P<0.001) was inversely significantly associated with NAFLD. In 334 non-diabetic NAFLD patients, age (OR: 1.035, P=0.025), high waist circumference (OR: 7.855, P<0.001), hypertriglyceridemia (OR: 2.152, P=0.011), and Log (ALT) (OR: 2.549, P=0.002) were directly associated with HOMA-IR, whereas Med-Diet score was inversely associated (OR: 0.801, P=0.018). CONCLUSIONS: We found an inverse relationship between Med-Diet and NAFLD prevalence. Among NAFLD patients, good adherence to Med-Diet was associated with lower insulin resistance. Our findings suggest that Med-Diet may be a beneficial nutritional approach in NAFLD patients.
OBJECTIVES: The prevalence of cardiometabolic disorders, including non-alcoholic fatty liver disease (NAFLD), is increasing in western countries, because of changes in lifestyle and dietary habits. Mediterranean Diet (Med-Diet) is effective for cardiovascular prevention, but its relationship with NAFLD has been scarcely investigated. METHODS: We included 584 consecutive outpatients presenting with one or more cardiovascular risk factor such as type 2 diabetes mellitus (T2DM), arterial hypertension, overweight/obesity, and dyslipidemia. Liver steatosis was assessed using ultrasonography. Med-Diet adherence was investigated by a validated semiquantitative nine-item dietary questionnaire; patients were divided into low, intermediate, and high adherence. Insulin resistance was defined by the 75th percentile of homeostasis model of insulin resistance (HOMA-IR; ≥3.8). RESULTS: The mean age was 56.2±12.4 years and 38.2% were women. Liver steatosis was present in 82.7%, and its prevalence decreased from low to high adherence group (96.5% vs. 71.4%, P<0.001). In a multiple logistic regression analysis, hypertriglyceridemia (odds ratio (OR): 2.913; P=0.002), log (ALT) (OR: 6.186; P<0.001), Med-Diet adherence (intermediate vs. low OR: 0.115; P=0.041, high vs. low OR: 0.093; P=0.030), T2DM (OR: 3.940; P=0.003), and high waist circumference (OR: 3.012; P<0.001) were associated with NAFLD. Among single foods, low meat intake (OR: 0.178; P<0.001) was inversely significantly associated with NAFLD. In 334 non-diabetic NAFLD patients, age (OR: 1.035, P=0.025), high waist circumference (OR: 7.855, P<0.001), hypertriglyceridemia (OR: 2.152, P=0.011), and Log (ALT) (OR: 2.549, P=0.002) were directly associated with HOMA-IR, whereas Med-Diet score was inversely associated (OR: 0.801, P=0.018). CONCLUSIONS: We found an inverse relationship between Med-Diet and NAFLD prevalence. Among NAFLD patients, good adherence to Med-Diet was associated with lower insulin resistance. Our findings suggest that Med-Diet may be a beneficial nutritional approach in NAFLD patients.
Authors: B Karamanos; A Thanopoulou; F Angelico; S Assaad-Khalil; A Barbato; M Del Ben; V Dimitrijevic-Sreckovic; P Djordjevic; C Gallotti; N Katsilambros; I Migdalis; M Mrabet; M Petkova; D Roussi; M T Tenconi Journal: Eur J Clin Nutr Date: 2002-10 Impact factor: 4.016
Authors: S García Cabrera; N Herrera Fernández; C Rodríguez Hernández; M Nissensohn; B Román-Viñas; L Serra-Majem Journal: Nutr Hosp Date: 2015-12-01 Impact factor: 1.057
Authors: Marissa Garcia; Jessica D Bihuniak; Julia Shook; Anne Kenny; Jane Kerstetter; Tania B Huedo-Medina Journal: Nutrients Date: 2016-03-15 Impact factor: 5.717
Authors: Elena S Papamiltiadous; Stuart K Roberts; Amanda J Nicoll; Marno C Ryan; Catherine Itsiopoulos; Agus Salim; Audrey C Tierney Journal: BMC Gastroenterol Date: 2016-02-02 Impact factor: 3.067
Authors: Theresia Sarabhai; Sabine Kahl; Julia Szendroedi; Daniel F Markgraf; Oana-Patricia Zaharia; Cristina Barosa; Christian Herder; Frithjof Wickrath; Pavel Bobrov; Jong-Hee Hwang; John Griffith Jones; Michael Roden Journal: JCI Insight Date: 2020-05-21
Authors: Elizabeth Marchlewicz; Carolyn McCabe; Zora Djuric; Mark Hoenerhoff; John Barks; Lu Tang; Peter X Song; Karen Peterson; Vasantha Padmanabhan; Dana C Dolinoy Journal: Chemosphere Date: 2021-07-29 Impact factor: 7.086
Authors: Vladimir T Ivashkin; Marina V Maevskaya; Elena N Shirokova; Igor V Maev; Alexey A Samsonov; Evgeniy I Sas; Liudmila K Palgova; Kirill Starostin Journal: Drugs Real World Outcomes Date: 2021-05-15